AR228874A1 - Procedimiento para la preparacion de un alto concentrado de factor viii(ahf) - Google Patents

Procedimiento para la preparacion de un alto concentrado de factor viii(ahf)

Info

Publication number
AR228874A1
AR228874A1 AR286519A AR28651981A AR228874A1 AR 228874 A1 AR228874 A1 AR 228874A1 AR 286519 A AR286519 A AR 286519A AR 28651981 A AR28651981 A AR 28651981A AR 228874 A1 AR228874 A1 AR 228874A1
Authority
AR
Argentina
Prior art keywords
ahf
procedure
preparation
factor viii
high factor
Prior art date
Application number
AR286519A
Other languages
English (en)
Spanish (es)
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of AR228874A1 publication Critical patent/AR228874A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions
AR286519A 1980-08-27 1981-08-24 Procedimiento para la preparacion de un alto concentrado de factor viii(ahf) AR228874A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0433880A AT369263B (de) 1980-08-27 1980-08-27 Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates

Publications (1)

Publication Number Publication Date
AR228874A1 true AR228874A1 (es) 1983-04-29

Family

ID=3562706

Family Applications (1)

Application Number Title Priority Date Filing Date
AR286519A AR228874A1 (es) 1980-08-27 1981-08-24 Procedimiento para la preparacion de un alto concentrado de factor viii(ahf)

Country Status (19)

Country Link
US (1) US4404131A (fi)
JP (1) JPS5928537B2 (fi)
AR (1) AR228874A1 (fi)
AT (1) AT369263B (fi)
BE (1) BE890003A (fi)
CA (1) CA1160567A (fi)
CH (1) CH652030A5 (fi)
DE (1) DE3129987C2 (fi)
DK (1) DK156764C (fi)
ES (1) ES8302017A1 (fi)
FI (1) FI72653C (fi)
FR (1) FR2489150A1 (fi)
GB (1) GB2083047B (fi)
HU (1) HU183542B (fi)
IT (1) IT1138511B (fi)
LU (1) LU83577A1 (fi)
NL (1) NL8103563A (fi)
NO (1) NO157884C (fi)
SE (1) SE459639B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555305B2 (en) * 1982-09-29 1986-09-18 Bayer Corporation Antihemophilic factor concentrate
US4650858A (en) * 1983-03-21 1987-03-17 Nordisk Gentofte A/S Concentrate of the antihemophilic factor VIII and a process for producing it
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
AU6487286A (en) * 1985-11-08 1987-05-14 Baxter Travenol Laboratories Inc. Antihemophilic factor by cold precipitation
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
PT2130554E (pt) 1999-02-22 2012-11-19 Univ Connecticut Formulações de factor viii isentas de albumina
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
US20100168018A1 (en) * 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
CN116322920A (zh) 2020-11-09 2023-06-23 武田药品工业株式会社 使用氧化硅吸附从血浆中纯化fviii

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
CA1101332A (fr) * 1976-01-30 1981-05-19 Edward Shanbrom Procedes simplifies pour la preparation de concentres de facteur viii de tres grande purete
DE2624373C2 (de) 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1054052A (en) 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii

Also Published As

Publication number Publication date
NO157884B (no) 1988-02-29
IT8123660A0 (it) 1981-08-27
BE890003A (fr) 1981-12-16
DE3129987C2 (de) 1984-11-29
DE3129987A1 (de) 1982-04-22
ES504859A0 (es) 1983-01-01
JPS5775928A (en) 1982-05-12
FI812567L (fi) 1982-02-28
FR2489150B1 (fi) 1984-06-29
SE8104482L (sv) 1982-02-28
CH652030A5 (de) 1985-10-31
JPS5928537B2 (ja) 1984-07-13
ATA433880A (de) 1982-05-15
NL8103563A (nl) 1982-03-16
LU83577A1 (de) 1981-12-01
NO812905L (no) 1982-03-01
GB2083047A (en) 1982-03-17
SE459639B (sv) 1989-07-24
NO157884C (no) 1988-06-15
DK156764B (da) 1989-10-02
ES8302017A1 (es) 1983-01-01
US4404131A (en) 1983-09-13
DK156764C (da) 1990-02-19
DK360281A (da) 1982-02-28
FR2489150A1 (fr) 1982-03-05
CA1160567A (en) 1984-01-17
FI72653C (fi) 1987-07-10
FI72653B (fi) 1987-03-31
IT1138511B (it) 1986-09-17
HU183542B (en) 1984-05-28
GB2083047B (en) 1984-03-28
AT369263B (de) 1982-12-27

Similar Documents

Publication Publication Date Title
ES524823A0 (es) Un procedimiento para la preparacion de nuevas fenetanolaminas
ES502906A0 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
AR228874A1 (es) Procedimiento para la preparacion de un alto concentrado de factor viii(ahf)
ES524768A0 (es) Procedimiento para preparar un concentrado de factor antihemofilico
ES526295A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo
ES506141A0 (es) Un procedimiento para la preparacion de piridin- y pira- cin-derivados
ES522595A0 (es) Un procedimiento para la preparacion de nuevos benzopiranos
ES531659A0 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES535980A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina
ES499559A0 (es) Un procedimiento para la preparacion de derivados de pirrol
ES530668A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos
AR229034A1 (es) Procedimiento para la preparacion de un polipeptido
ES505345A0 (es) Un procedimiento para la preparacion de 1,1,1',1'-tetraoxidode penicilanato de penicilanoiloximetilo
ES503565A0 (es) Un procedimiento para la preparacion de tilactona o un esterderivado de la misma
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES500911A0 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES528622A0 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
AR230187A1 (es) Procedimiento para la preparacion de un concentrado de factor antihemofilico
ES499572A0 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
ES498145A0 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas
ES506097A0 (es) Un procedimiento para la preparacion de nuevas prostaglandi-nas
ES501277A0 (es) Un procedimiento para la preparacion de perfluoroamidas
ES526400A0 (es) Un procedimiento para la preparacion de pirrolopirroles
ES525961A0 (es) Un procedimiento para la preparacion de a53868 factor a
ES539247A0 (es) Un procedimiento para la preparacion de benzotienil-, benzofuranil o naftil-derivados